Open AccessLiver Transplantation for Cholangiocarcinoma and Mixed Hepatocellular Cholangiocarcinoma: Working Group Report From the ILTS Transplant Oncology Consensus Conference
Author(s) -
Gonzalo Sapisochín,
Milind Javle,
Jan Lerut,
Masayuki Ohtsuka,
Rafik M. Ghobrial,
Taizo Hibi,
Nancy Man Kwan,
Julie K. Heimbach
Publication year - 2020
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0000000000003212
Subject(s) - contraindication , medicine , liver transplantation , consensus conference , hepatocellular carcinoma , transplantation , general surgery , intrahepatic cholangiocarcinoma , surgical oncology , hepatocellular cancer , oncology , gastroenterology , pathology , alternative medicine
Liver transplantation for cholangiocarcinoma has been an absolute contraindication worldwide due to poor results. However, in recent years and thanks to improvements of patient management and treatments of this cancer, this indication has been revisited. This consensus paper, approved by the International Liver Transplant Society, aims to provide a collection of expert opinions, consensus, and best practices surrounding liver transplantation for cholangiocarcinoma.